Italian article, translated: https://www.ilsuss
Post# of 148183
(Total Views: 622)
Posted On: 05/01/2020 12:10:45 PM
Italian article, translated:
https://www.ilsussidiario.net/news/leronlimab...o/2017188/
Leronlimab against Coronavirus / Excellent test results: will it be decisive?
Publication: 01.05.2020- Mauro Mantegazza
Leronlimab against Coronavirus: excellent results from tests conducted on this drug in America, the hope is that it will be decisive.
Coronavirus research
Archive image (LaPresse)
Advertising
Studies continue on leronlimab , one of the drugs that could be used against Coronavirus : the results obtained so far really bode well. The American CytoDyn Inc , biotechnology company, is testing the drug Leronlimab - normally used against HIV and tumors - on Coronavirus patients, as we had already told you a few weeks ago : updates on this experiment were announced yesterday involving 49 people, Covid-19 patients who received leronlimab.
The indications are really positive. Twelve of them were hospitalized in New York , all in serious conditions in intensive care and also other previous pathologies to further complicate the clinical picture: all showed improvements and for at least four we can really talk about a saved life, according to what reported in the press release CytoDyn.
Another 23 patients were hospitalized in a Southern California hospital : six intubated, of which only one showed a worsening of their condition while three were extubated ; among the other 17, there were significant improvements in 11 cases, of which eight were discharged .
Advertising
LERONLIMAB AGAINST CORONAVIRUS: EXCELLENT RESULTS FROM TESTS
In Georgia three patients, all intubated and with previous pathologies: all showed improvements and two were extubated. Ten patients who started treatment with leronlimab are still awaiting feedback and in the meantime five other names have been added, therefore in total the study will involve 54 patients .
Nader Pourhassan , president and CEO of CytoDyn, speaks of " impressive results " and therefore has high hopes for the subsequent phases of experimenting with the treatment of Coronavirus with leronlimab . The procedures for these next steps are proceeding rapidly and "we believe that the results will be very significant thanks to the mechanism of action that reactivates the immune system ".
CytoDyn in fact plans further tests to verify the effect of leronlimab both on other serious patients and on those who have moderate symptoms. Leronlimab, as already mentioned, is usually used to treat patients with HIV, as well as for cancer patients, as it is a cellular receptor that blocks HIV infection , as well as tumor metastases. Could it also be decisive in the war against Coronavirus? The results obtained so far really bode well ...
© RESERVED REPRODUCTION
https://www.ilsussidiario.net/news/leronlimab...o/2017188/
Leronlimab against Coronavirus / Excellent test results: will it be decisive?
Publication: 01.05.2020- Mauro Mantegazza
Leronlimab against Coronavirus: excellent results from tests conducted on this drug in America, the hope is that it will be decisive.
Coronavirus research
Archive image (LaPresse)
Advertising
Studies continue on leronlimab , one of the drugs that could be used against Coronavirus : the results obtained so far really bode well. The American CytoDyn Inc , biotechnology company, is testing the drug Leronlimab - normally used against HIV and tumors - on Coronavirus patients, as we had already told you a few weeks ago : updates on this experiment were announced yesterday involving 49 people, Covid-19 patients who received leronlimab.
The indications are really positive. Twelve of them were hospitalized in New York , all in serious conditions in intensive care and also other previous pathologies to further complicate the clinical picture: all showed improvements and for at least four we can really talk about a saved life, according to what reported in the press release CytoDyn.
Another 23 patients were hospitalized in a Southern California hospital : six intubated, of which only one showed a worsening of their condition while three were extubated ; among the other 17, there were significant improvements in 11 cases, of which eight were discharged .
Advertising
LERONLIMAB AGAINST CORONAVIRUS: EXCELLENT RESULTS FROM TESTS
In Georgia three patients, all intubated and with previous pathologies: all showed improvements and two were extubated. Ten patients who started treatment with leronlimab are still awaiting feedback and in the meantime five other names have been added, therefore in total the study will involve 54 patients .
Nader Pourhassan , president and CEO of CytoDyn, speaks of " impressive results " and therefore has high hopes for the subsequent phases of experimenting with the treatment of Coronavirus with leronlimab . The procedures for these next steps are proceeding rapidly and "we believe that the results will be very significant thanks to the mechanism of action that reactivates the immune system ".
CytoDyn in fact plans further tests to verify the effect of leronlimab both on other serious patients and on those who have moderate symptoms. Leronlimab, as already mentioned, is usually used to treat patients with HIV, as well as for cancer patients, as it is a cellular receptor that blocks HIV infection , as well as tumor metastases. Could it also be decisive in the war against Coronavirus? The results obtained so far really bode well ...
© RESERVED REPRODUCTION
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼